Overview

This trial is active, not recruiting.

Condition aortic dissection
Sponsor Xiang Ma
Start date February 2015
End date March 2016
Trial size 100 participants
Trial identifier NCT02378103, IACUC-20140214090

Summary

To evaluate epidemiological features of risk factors for aortic dissection (AD) in Chinese XinJiang Province patients.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case control
Time perspective retrospective
Arm
Diagnosis of aortic dissection was based on history and physical examination, and confirmed by imaging, visualization at surgery, and/or postmortem examination. Simple aortic aneurysm and pseudoaneurysm were excluded. Simple aortic aneurysm and pseudoaneurysm were excluded. Surgical and endovascular treatments were the main interventions and performed in the case group.
As the control group, patients without AD were obtained from the hospitalized patients in the same period.

Primary Outcomes

Measure
Participants with related events for aortic dissection in Chinese XinJiang population
time frame: 1 year

Eligibility Criteria

Male or female participants from 18 years up to 80 years old.

Inclusion Criteria: 1. Clinical diagnosis of aortic dissection 2. ≥18 years old 3. good compliance with the instructions and cooperate with follow-up voluntarily signed the informed consent form Exclusion Criteria: 1. pregnant or lactating female 2. bad compliance with the instructions and follow-up 3. estimated remaining life is less than 12 months 4. Aortic aneurysm、Acute Myocardial infarction、Acute Cerebral accident

Additional Information

Description The epidemiological features of risk factors for aortic dissection (AD) in China were obtained from developed population in east of China, however, such information was not available for the remote population. Moreover, people in the western region have significant difference with developed population in lifestyle, diet, ethnic and so on. Therefore, the aim of our study was to evaluate epidemiological features of risk factors for AD in Chinese remote patients. We anticipated that this analysis would provide helpful information preventing and controlling AD in Chinese XinJiang Province.
Trial information was received from ClinicalTrials.gov and was last updated in February 2016.
Information provided to ClinicalTrials.gov by First Affiliated Hospital of Xinjiang Medical University.